Annual Cash & Cash Equivalents
$262.99 M
-$238.20 M-47.53%
29 December 2023
Summary:
Exelixis annual cash & cash equivalents is currently $262.99 million, with the most recent change of -$238.20 million (-47.53%) on 29 December 2023. During the last 3 years, it has fallen by -$384.18 million (-59.36%). EXEL annual cash & cash equivalents is now -59.36% below its all-time high of $647.17 million, reached on 31 December 2021.EXEL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$258.35 M
+$59.89 M+30.18%
27 September 2024
Summary:
Exelixis quarterly cash and cash equivalents is currently $258.35 million, with the most recent change of +$59.89 million (+30.18%) on 27 September 2024. Over the past year, it has dropped by -$4.65 million (-1.77%). EXEL quarterly cash and cash equivalents is now -64.28% below its all-time high of $723.27 million, reached on 01 March 2022.EXEL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXEL Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -1.8% |
| 3 y3 years | -59.4% | -60.1% |
| 5 y5 years | -1.3% | -3.1% |
EXEL Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.4% | at low | -64.3% | +30.2% |
| 5 y | 5 years | -59.4% | at low | -64.3% | +30.2% |
| alltime | all time | -59.4% | +4770.3% | -64.3% | +4359.6% |
Exelixis Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $258.35 M(+30.2%) |
| June 2024 | - | $198.46 M(-23.5%) |
| Mar 2024 | - | $259.56 M(-1.3%) |
| Dec 2023 | $262.99 M(-47.5%) | $262.99 M(-33.7%) |
| Sept 2023 | - | $396.86 M(-14.6%) |
| June 2023 | - | $464.48 M(-14.1%) |
| Mar 2023 | - | $540.60 M(+7.9%) |
| Dec 2022 | $501.19 M(-22.6%) | $501.19 M(-25.8%) |
| Sept 2022 | - | $675.29 M(+7.7%) |
| June 2022 | - | $627.00 M(-13.3%) |
| Mar 2022 | - | $723.27 M(+11.8%) |
| Dec 2021 | $647.17 M(+102.7%) | $647.17 M(+14.1%) |
| Sept 2021 | - | $567.33 M(+15.2%) |
| June 2021 | - | $492.46 M(+33.0%) |
| Mar 2021 | - | $370.21 M(+16.0%) |
| Dec 2020 | $319.22 M(+19.8%) | $319.22 M(-4.4%) |
| Sept 2020 | - | $334.05 M(-36.6%) |
| June 2020 | - | $527.14 M(+47.5%) |
| Mar 2020 | - | $357.34 M(+34.1%) |
| Dec 2019 | $266.50 M(-15.3%) | $266.50 M(+10.0%) |
| Sept 2019 | - | $242.32 M(-34.5%) |
| June 2019 | - | $369.79 M(-1.1%) |
| Mar 2019 | - | $373.94 M(+18.8%) |
| Dec 2018 | $314.77 M(+71.9%) | $314.77 M(-11.0%) |
| Sept 2018 | - | $353.62 M(+42.4%) |
| June 2018 | - | $248.41 M(+6.9%) |
| Mar 2018 | - | $232.33 M(+26.8%) |
| Dec 2017 | $183.16 M(+20.8%) | $183.16 M(+22.6%) |
| Sept 2017 | - | $149.36 M(+10.5%) |
| June 2017 | - | $135.21 M(-26.2%) |
| Mar 2017 | - | $183.18 M(+20.8%) |
| Dec 2016 | $151.69 M(+7.1%) | $151.69 M(+36.4%) |
| Sept 2016 | - | $111.22 M(-14.3%) |
| June 2016 | - | $129.83 M(-53.1%) |
| Mar 2016 | - | $276.88 M(+95.5%) |
| Dec 2015 | $141.63 M(+76.2%) | $141.63 M(-2.8%) |
| Sept 2015 | - | $145.64 M(+135.1%) |
| June 2015 | - | $61.95 M(-27.1%) |
| Mar 2015 | - | $84.99 M(+5.7%) |
| Dec 2014 | $80.39 M(-22.7%) | $80.39 M(-19.7%) |
| Sept 2014 | - | $100.06 M(-32.1%) |
| June 2014 | - | $147.34 M(-6.5%) |
| Mar 2014 | - | $157.54 M(+51.5%) |
| Dec 2013 | $103.98 M(-38.9%) | $103.98 M(+13.0%) |
| Sept 2013 | - | $92.02 M(-30.2%) |
| June 2013 | - | $131.77 M(-23.0%) |
| Mar 2013 | - | $171.23 M(+0.7%) |
| Dec 2012 | $170.07 M | $170.07 M(-44.9%) |
| Sept 2012 | - | $308.81 M(+353.2%) |
| June 2012 | - | $68.14 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $70.47 M(-5.1%) |
| Dec 2011 | $74.26 M(-23.8%) | $74.26 M(+12.2%) |
| Sept 2011 | - | $66.21 M(-12.0%) |
| June 2011 | - | $75.28 M(-62.7%) |
| Mar 2011 | - | $202.05 M(+107.4%) |
| Dec 2010 | $97.44 M(+12.3%) | $97.44 M(+2.2%) |
| Sept 2010 | - | $95.34 M(-39.4%) |
| June 2010 | - | $157.20 M(+169.7%) |
| Mar 2010 | - | $58.29 M(-32.8%) |
| Dec 2009 | $86.80 M(-65.0%) | $86.80 M(-49.1%) |
| Sept 2009 | - | $170.57 M(+11.5%) |
| June 2009 | - | $152.91 M(-24.1%) |
| Mar 2009 | - | $201.43 M(-18.7%) |
| Dec 2008 | $247.70 M(+82.9%) | $247.70 M(+285.6%) |
| Sept 2008 | - | $64.23 M(-14.4%) |
| June 2008 | - | $75.05 M(-38.4%) |
| Mar 2008 | - | $121.88 M(-10.0%) |
| Dec 2007 | $135.46 M(+9.8%) | $135.46 M(-4.2%) |
| Sept 2007 | - | $141.33 M(+33.8%) |
| June 2007 | - | $105.61 M(-26.6%) |
| Mar 2007 | - | $143.84 M(+16.6%) |
| Dec 2006 | $123.37 M(+51.7%) | $123.37 M(+121.5%) |
| Sept 2006 | - | $55.70 M(-35.2%) |
| June 2006 | - | $86.02 M(-38.6%) |
| Mar 2006 | - | $140.10 M(+72.3%) |
| Dec 2005 | $81.33 M(+4.1%) | $81.33 M(-9.6%) |
| Sept 2005 | - | $90.01 M(-14.1%) |
| June 2005 | - | $104.82 M(+70.8%) |
| Mar 2005 | - | $61.38 M(-21.4%) |
| Dec 2004 | $78.11 M(-30.2%) | $78.11 M(+62.7%) |
| Sept 2004 | - | $47.99 M(+23.3%) |
| June 2004 | - | $38.92 M(-51.5%) |
| Mar 2004 | - | $80.32 M(-28.2%) |
| Dec 2003 | $111.83 M(+23.9%) | $111.83 M(+103.1%) |
| Sept 2003 | - | $55.06 M(-19.7%) |
| June 2003 | - | $68.57 M(-6.3%) |
| Mar 2003 | - | $73.15 M(-19.0%) |
| Dec 2002 | $90.28 M(+153.7%) | $90.28 M(+207.8%) |
| Sept 2002 | - | $29.34 M(+406.4%) |
| June 2002 | - | $5.79 M(-73.0%) |
| Mar 2002 | - | $21.44 M(-39.7%) |
| Dec 2001 | $35.58 M(+82.0%) | $35.58 M(-16.9%) |
| Sept 2001 | - | $42.81 M(-7.1%) |
| June 2001 | - | $46.06 M(+17.8%) |
| Mar 2001 | - | $39.11 M(+100.1%) |
| Dec 2000 | $19.55 M(+262.1%) | $19.55 M(-50.3%) |
| Sept 2000 | - | $39.32 M(-23.5%) |
| June 2000 | - | $51.42 M(+328.4%) |
| Mar 2000 | - | $12.00 M |
| Dec 1999 | $5.40 M | - |
FAQ
- What is Exelixis annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Exelixis?
- What is Exelixis quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Exelixis?
- What is Exelixis quarterly cash and cash equivalents year-on-year change?
What is Exelixis annual cash & cash equivalents?
The current annual cash & cash equivalents of EXEL is $262.99 M
What is the all time high annual cash & cash equivalents for Exelixis?
Exelixis all-time high annual cash & cash equivalents is $647.17 M
What is Exelixis quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EXEL is $258.35 M
What is the all time high quarterly cash and cash equivalents for Exelixis?
Exelixis all-time high quarterly cash and cash equivalents is $723.27 M
What is Exelixis quarterly cash and cash equivalents year-on-year change?
Over the past year, EXEL quarterly cash and cash equivalents has changed by -$4.65 M (-1.77%)